Table 2. Numbers and percentages of TMB-high patients within each cancer type with the TMB cutoff set to 10 mutations/Mb.

Tumor type (number of patients with overall survival)*	Numbers and percentages of TMB-high cases (n, %)
Cholangiocarcinoma (n=62)	4 (6.45)
Nervous system tumor (n=27)	4 (14.81)
Gastric cancer (n=16)	1 (6.25)
Hepatocellular carcinoma (n=98)	6 (6.12)
Colorectal cancer (n=66)	17 (25.76)

*, to compare patient outcomes with different TMB status, only patients with overall survival were included in this table. TMB, tumor mutational burden.